PRODUCT
首頁
產品資訊
PRODUCT
首頁
產品資訊
產品特點
| 編號 | 名稱 | 描述 | 純度 |
| HB7279 | Lac-Phe-d5 (N-lactoyl-phenylalanine-d5) | Deuterated Lac-Phe (N-lactoyl-phenylalanine) | >97% |
| HB4674 | (+)-Abscisic acid | Phytohormone and endogenous lanthionine synthetase C-like 2 (LANCL2) ligand | >99% |
| HB1477 | Actinomycin D | RNA polymerase inhibitor. Apoptosis inducer. | >98% |
| HB3742 | Aftin-4 | Roscovitine-related purine with no activity on CDKs. Roscovitine control. Increases Aβ42 production. | >98% |
| HB3742 | Aftin-5 | Roscovitine-related purine with no activity on CDKs. Roscovitine control. Increases Aβ42 production. | >98% |
| HB3729 | 6-Amino-8-trifluoromethylphenanthridine | Ribosome-borne protein folding activity (RPFA) inhibitor | >99% |
| HB3730 | 6-Aminophenanthridine | Ribosome-borne protein folding activity (RPFA) inhibitor | >99% |
| HB8758 | β-Amyloid Peptide (1-40) (human) | β-Amyloid (1-40) protein fragment. | |
| HB9805 | β-Amyloid Peptide (1-42) (human) | β-Amyloid (1-42) protein fragment. Implicated in Alzheimer's disease. | |
| HB8524 | β-Amyloid Peptide (25-35) (human) | β-Amyloid (25-35) protein fragment | |
| HB9159 | β-Amyloid Peptide (42-1) (human) | β-Amyloid Peptide (1-42) inactive control. | |
| HB3690 | Aphidicolin | DNA replication inhibitor. Useful for cell synchronization | >98% |
| HB4602 | Azidothymidine | Selective reverse transcriptase inhibitor with anti-HIV activity. Decreases CRISPR-mediated homology directed repair (HDR) and enhances gene knockout efficiency. | |
| HB4336 | Azithromycin | Antibiotic and protein synthesis inhibitor | >98% |
| HB0979 | BrdU (5-Bromo-2′-deoxyuridine) | Thymidine analog. Widely used to identify proliferating cells, enhances Yamanaka factor reprogramming | >98% |
| HB3824 | Carboplatin | Cisplatin analog. Blocks DNA replication and transcription. | >98% |
| HB5062 | CCCP | Potent uncoupler of mitochondrial oxidative phosphorylation | >98% |
| HB4376 | Daunorubicin hydrochloride | RNA and DNA synthesis inhibitor. Antibiotic. | |
| HB3723 | 3-Deoxyaphidicolin | Specific DNA polymerase α inhibitor | >98% |
| HB4183 | Doxorubicin hydrochloride | Antibiotic. DNA topisomerase II inhibitor. | >99% |
| HB4608 | Doxycycline hyclate | Broad-spectrum antibiotic. Used in inducible Tet-on/ Tet-off gene expression systems for gene editing. | >95% |
| HB7389 | Emetine dihydrochloride | Protein synthesis inhibitor | |
| HB2903 | FCCP | Potent uncoupler of mitochondrial oxidative phosphorylation | >98% |
| HB3906 | G418 disulfate salt | Antibiotic. Widely used in cell culture. Protein synthesis inhibitor | |
| HB3263 | Gatifloxacin | Antibiotic; bacterial type II topoisomerase inhibitor. Activates ESC short term renewal. | >98% |
| HB4660 | Homoharringtonine | Protein synthesis inhibitor | >98% |
| HB6040 | 4-Hydroxytamoxifen ≥70% Z isomer (remainder primarily E-isomer) | Synthetic estrogen receptor ligand. Widely used in genome engineering (e.g. CreER/ CRISPR-Cas9) | >98% |
| HB6095 | 4-Hydroxytamoxifen (E) and (Z) isomers (50:50) | Synthetic estrogen receptor ligand. Widely used in genome engineering (e.g. CreER/ CRISPR-Cas9) | >98% |
| HB2508 | (Z)-4-Hydroxytamoxifen (Z-4-OHT) | Synthetic estrogen receptor ligand. Widely used in genome engineering (e.g. CreER/ CRISPR-Cas9). | >98% |
| HB4420 | Hygromycin B | Bacterial selection antibiotic. Protein synthesis inhibitor | |
| HB4429 | Kanamycin sulfate | Protein synthesis inhibitor. Broad spectrum antibiotic | |
| HB8782 | Lac-Phe (N-lactoyl-phenylalanine) | Exercise induced metabolite that supresses food intake and obesity | >97% |
| HB4443 | Linezolid | Inhibits protein synthesis in gram-positive bacteria. Antibiotic | |
| HB5252 | Methoxy-X04 | Fluorescent amyloid β stain. BBB permeable. | >98% |
| HB4458 | Mitomycin C | Antibiotic. DNA synthesis inhibitor. | |
| HB3992 | Nebularine | Naturally occuring nucleoside. DNA, RNA and protein synthesis inhibitor | >98% |
| HB9790 | 1% NH4OH solution | 1% NH4OH solution which can be used as the solvent for Beta-Amyloid (1-42) and (1-40) peptides | |
| HB3999 | Nocodazole | Mitosis inhibitor, widely used as a cell cycle synchronizing agent. Enhances HDR efficiency and increases Cas9-mediated gene editing frequencies. | >98% |
| HB4488 | Oligomycin A | Inhibitor of mitochondrial function | |
| HB0820 | Propidium Iodide | Red-fluorescent cell viability stain | |
| HB0821 | Propidium Iodide Staining Solution (1mg/ml) in water | Red-fluorescent cell viability stain. 1mg/ml staining solution in water | |
| HB2779 | Rapamycin | mTOR inhibitor and potent immunosuppressant. Also used in inducible gene editing methods (e.g. CRISPR/Cas9) and promotes hPSC differentiation. | >98% |
| HB2567 | Rifampicin | Antibiotic. Inhibits RNA synthesis. | >98% |
| HB2568 | Rifaximin | Antibiotic and Pregane X receptor agonist | |
| HB5398 | Rotenone | Mitochondrial Complex I Inhibitor. Induces mitochondrial dysfunction. | |
| HB5647 | RS-1 | hRAD51 stimulator. Enhances CRISPR genome editing efficiency. | >99% |
| HB4097 | Streptozocin | Antibiotic. Diabetes inducer. | >98% |
| HB4564 | Tobramycin | Aminoglycoside antibiotic |